Revel Pharmaceuticals

Revel Pharmaceuticals

Biotechnology Research San Francisco, California, United States 9 employees
Employees
9
Contacts
3
Emails
3

Revel Pharmaceuticals Overview

Headquarters
San Francisco, California, United States
Phone Number
Available in AeroLeads
Industry
Biotechnology Research
Employees
9
Founded
2019
Funding
8.4M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords

About Revel Pharmaceuticals

Revel Pharmaceuticals is a biotechnology commercializing therapeutic enzymes to degrade age associated molecule damage. We are targeting pathological, age associated compounds known as Advanced Glycation End Products (AGEs) which build up on long lived proteins like collagen. AGE accumulation is implicated in multiple diseases of aging, thus Revel Pharmaceuticals is strategically positioned to develop therapeutics across multiple indications.

Revel Pharmaceuticals Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage

Revel Pharmaceuticals Org Chart

Sample employees and titles
Name Title Contact
Maggie Yun-Hsuan Hsu Research Associate @ Revel Pharmaceuticals
Email
Aaron Cravens CEO at Revel Pharmaceuticals
Email
Kevin Desai Head of Enzyme Engineering at Revel Pharmaceuticals
View
Narisa Trabosh Associate Scientist at Revel Pharmaceuticals
Email

Employees by Management Level

Associate / junior 4 profiles
Executive 1 profile
VP / Head 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 2 2 0

Revel Pharmaceuticals Tech Stack

Data / AI 2 profiles
Engineering 1 profile

Compare Similar Companies to Revel Pharmaceuticals